Application 091273
- Type
- ANDA
- Sponsor
- SANDOZ
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 500MG;EQ 15MG BASE | No | No |
| 002 | PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE | TABLET;ORAL | 850MG;EQ 15MG BASE | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0781-5626 | Pioglitazone and metformin | Pioglitazone and metformin | Sandoz Inc | ANDA | Current |
| 0781-5626 | Pioglitazone and metformin | Pioglitazone and metformin | Sandoz Inc | ANDA | Current |
| 0781-5627 | Pioglitazone and metformin | Pioglitazone and metformin | Sandoz Inc | ANDA | Current |
| 0781-5627 | Pioglitazone and metformin | Pioglitazone and metformin | Sandoz Inc | ANDA | Current |
| 70882-105 | Pioglitazone and metformin | Pioglitazone and metformin | Cambridge Therapeutics Technologies, LLC | ANDA | Current |